Ovalink SR Tablet is a sustained-release formulation combining Dehydroepiandrosterone (DHEA) micronized 75 mg, Folic Acid 4.5 mg, and Vitamin D3 3000 IU, designed to support endocrine and metabolic health. DHEA, a naturally occurring steroid hormone precursor, plays a critical role in the biosynthesis of androgens and estrogens, contributing to improved hormonal balance, enhanced mood, and cognitive function. The micronized form facilitates better absorption and bioavailability. Folic Acid, a vital B-vitamin, is essential for DNA synthesis, cellular division, and neural tube development, making it crucial in preconception care and during pregnancy to prevent neural tube defects. Vitamin D3, a fat-soluble vitamin, is integral to calcium homeostasis and bone metabolism, promoting skeletal health and immune modulation. The sustained-release mechanism ensures a gradual release of active ingredients, optimizing therapeutic efficacy and minimizing plasma concentration fluctuations. Ovalink SR is indicated for individuals with hormonal imbalances, folate deficiency, or Vitamin D insufficiency, and may be beneficial in managing conditions such as adrenal insufficiency, osteoporosis risk, and pregnancy-related nutritional needs. It should be used under medical supervision, with dosage adjustments based on clinical response and laboratory parameters. Contraindications include hypersensitivity to any component and hypercalcemia. Regular monitoring of serum calcium, folate, and hormone levels is recommended during therapy.